Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab
September 2025
Psoriatic disease extends beyond the skin, imposing a significant psychosocial burden, often leading to embarrassment, social withdrawal…
Read more
12 Sep 2025
The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab
Psoriatic disease extends beyond the skin, imposing a significant psychosocial burden, often leading to embarrassment, social withdrawal…
3
Mins
11 Sep 2025
Development of Phage Therapies for Acne Vulgaris
Acne vulgaris, commonly known as acne, is a skin disease caused by the blockage of hair follicles, high keratin and sebum production in…
5
Mins
11 Sep 2025
Anti-IL-23 Blocks Pathogenic T Cells
Psoriasis affects 60 million people globally. It is an inflammatory skin condition that can significantly impact quality of life…
10
Mins
21 Aug 2025
The evolving atopic dermatitis treatment landscape
Experts provide real-life insights and case examples of managing moderate-to-severe atopic dermatitis, sharing their treatment experience with lebrikizumab.
11
Mins
12 Jun 2025
Acne Treatment Review and Present Perspectives
Acne is a chronic inflammatory skin disease whose visible effects can have a significant psychological impact on patients. A multimodal…
29 May 2025
Article Under Review
3
Mins
11 Mar 2025
Nemolizumab in Atopic Dermatitis
Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…
30 Jan 2025
Vitiligo, Beyond White Patches
A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and…
17 Dec 2024
Tralokinumab in the Era of Disruption in Atopic Dermatitis
Gain valuable insights from three atopic dermatitis (AD) specialists who specifically consider one of the newest systemic therapies that targets the cytokine IL-13, a key cytokine involved in the pathogenesis of AD.
9
Mins
7 Nov 2024
Epigenetics to Reverse Skin Ageing
Epigenetic changes drive skin aging by silencing the expression of youthful genes. Experts discussed the discovery of epicelline, an…
11
Mins
7 Nov 2024
Vitiligo, Beyond White Patches
A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and…
6
Mins
7 Nov 2024
Mechanisms of Response to Bimekizumab for Psoriatic Disease
Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based on…
14
Mins
7 Nov 2024
Skin Microbiome and Acne
Marco Rocha, Thomas Dirschka, and Alison Layton discuss the current acne landscape, the potential role of the skin microbiome in acne…
10
Mins
7 Nov 2024
Therapies for AGA
Androgenetic alopecia (AGA) is the leading cause of hair loss in both men and women. Experts outline current and emerging therapies in the…
11
Mins
7 Nov 2024
Tralokinumab in Atopic Dermatitis
To discuss how biologics have disrupted clinical management of atopic dermatitis, and how tralokinumab fits into this paradigm, the EMJ sat…
4
Mins
7 Nov 2024
Advances in Treatment for Hair Loss Conditions
Hair loss is a common problem in clinical dermatology, with many aetiologies including but not limited to androgenetic alopecia…
8
Mins
7 Nov 2024
Update on Low-Molecular Weight Hyaluronic Acid
Hyaluronan, or hyaluronic acid (HA), is an extracellular matrix glycosaminoglycan distributed throughout the body, primarily found in…
5
Mins
7 Nov 2024
Autosomal Recessive Congenital Ichthyosis: Report of an Attenuated Phenotype
Congenital ichthyosis represents keratinisation disorders characterised by abnormal skin scaling across the entire body, leading to a red…
5
Mins
7 Nov 2024
Pigmented Variants of Basal Cell Carcinoma
Basal cell carcinoma (BCC) is a heterogeneous malignant neoplasm and can cause great morbidity as most occur in highly visible areas of…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
9
Mins
23 Oct 2024
Interview: Chesahna Kindred
Now, as a practicing physician, I have no insecurities about being a woman in business, because in my training, I would be in a room with hundreds of women at the Women’s Dermatological Society.
14
Mins
12 Sep 2024
Clinical Practice Insights for Hyperpigmentation Treatment
Hyperpigmentation disorders, a group of common skin conditions characterised by darkened patches due to excess melanin production, affect…
12
Mins
9 Aug 2024
Reviewing Non-Scarring Alopecia in Women
Scalp hair is often regarded as a symbol of beauty and vitality across many cultures. Consequently, the loss of hair can significantly…
9
Mins
13 Jun 2024
Dermatitis Artefacta Treatment
Dermatitis artefacta (DA), also known as artefactual skin disease, is a rare psychocutaneous disorder characterised by…
Loading posts...
« Previous
1
2
3
4
5
…
28
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View